CITIGROUP INC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$53100
-27.5%
0.00%
Q2 2022$0
-100.0%
138
-72.4%
0.00%
Q2 2021$3,000
+50.0%
5000.0%0.00%
Q1 2021$2,000
-33.3%
500
-50.0%
0.00%
Q4 2020$3,0000.0%1,0000.0%0.00%
Q3 2020$3,000
-66.7%
1,000
-63.1%
0.00%
Q2 2020$9,000
-67.9%
2,707
-62.4%
0.00%
Q1 2020$28,000
-33.3%
7,206
+3.8%
0.00%
Q4 2019$42,000
+55.6%
6,940
+93.4%
0.00%
Q3 2019$27,000
+285.7%
3,588
+590.0%
0.00%
Q2 2019$7,000
+133.3%
520
+4.0%
0.00%
Q1 2019$3,000
+200.0%
5000.0%0.00%
Q4 2018$1,000
-75.0%
5000.0%0.00%
Q3 2018$4,000
-20.0%
5000.0%0.00%
Q2 2018$5,000
+25.0%
500
-2.3%
0.00%
Q1 2018$4,000
-55.6%
512
-25.3%
0.00%
Q4 2017$9,000
-78.0%
685
-86.1%
0.00%
Q3 2017$41,000
-98.9%
4,912
-97.8%
0.00%
-100.0%
Q2 2017$3,762,000
+11300.0%
221,698
+13501.1%
0.00%
Q1 2017$33,000
+106.2%
1,630
+63.0%
0.00%
Q4 2016$16,000
+23.1%
1,0000.0%0.00%
Q3 2016$13,000
-45.8%
1,000
-61.0%
0.00%
Q1 2016$24,000
+140.0%
2,562
+139.7%
0.00%
Q4 2015$10,0001,0690.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Beryl Capital Management LLC 4,898,927$6,246,1320.70%
Yakira Capital Management, Inc. 620,019$790,5240.22%
Crystalline Management Inc. 230,817$294,2920.21%
DELTEC ASSET MANAGEMENT LLC 475,000$605,6250.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,283,979$2,912,0730.12%
PenderFund Capital Management Ltd. 123,444$2130.06%
FIFTH LANE CAPITAL, LP 100,000$127,0000.04%
CSS LLC/IL 476,831$607,9600.04%
Penserra Capital Management LLC 220,858$2800.01%
King Wealth Management Group 16,000$200.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders